Filing Flows › Health Care › LogicMark (LGMK)
LogicMark (LGMK) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 19, 2026 · LogicMark (LGMK) Q2 2026 earnings results →
Q2 2026 Revenue up 17% year over year to $3.3M · 46¢ of every $1 of revenue lost · operating margin -47.6%
LogicMark made $3.3M in Q2 2026 (+17% Y/Y): Product $3.1M, Subscription $249K. Operating margin -47.6%, net loss $1.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 19, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $3.3M in Q2 2026, up 17% year over year and up 4% from the previous quarter. Product was the largest line at 93% of revenue. Product added $374K year over year (up 14%), 75% of the total change.
Gross margin was 70.7%, up 3.2 points from Q2 2025. Operating costs exceeded revenue by $1.6M, an operating margin of -47.6%. Operating expenses fell 2% while revenue rose 17%. The fastest-growing cost line was Other operating costs (+112%). The quarter ended with a net loss of $1.6M, wider than the previous quarter's $1.5M loss.
Operating cash flow was $83K. Non-cash charges added back $599K of depreciation and amortization and $432K of share-based compensation. Working capital and other items added $605K. Capital expenditures of $35K left free cash flow of $48K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 19, 2026 | $3.3M | +17% | -47.6% | −$1.6M | $83K |
| Q1 2026 | 10-Q | May 15, 2026 | $3.2M | +24% | -46.8% | −$1.5M | −$1.6M |
| Q4 2025 | 10-K | Mar 27, 2026 | $3.1M | +36% | -54.5% | −$1.6M | −$1.6M |
| Q3 2025 | 10-Q | Nov 13, 2025 | $2.9M | +8% | -59.6% | −$1.6M | −$759K |
| Q2 2025 | 10-Q | Aug 13, 2025 | $2.9M | +22% | -74.7% | −$2.1M | −$1.0M |
| Q1 2025 | 10-Q | May 15, 2025 | $2.6M | -0.7% | -91.2% | −$2.2M | −$1.7M |
| Q4 2024 | 10-K | Mar 31, 2025 | $2.2M | -7% | -97.6% | −$3.7M | −$993K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About LogicMark
LogicMark, Inc. (quoted on the over-the-counter market under the symbol LGMK) (“LogicMark”, the “Company”, “we”, “us” or “our”) provides personal emergency response systems (“PERS”), health communications devices, and Internet of Things (“IoT”) technology that creates a connected care platform. The Company’s devices provide people with the ability to receive care at home and age independently. The Company’s PERS devices incorporate two-way voice communication technology directly in the medical alert pendant and provide life-saving technology at a customer-friendly price point aimed at everyday consumers. These PERS technologies, as well as other personal safety devices are sold direct-to-consumer through the Company’s eCommerce website and Amazon.com, through dealers and resellers, as well as directly to the United States Veterans Health Administration (“VHA”).
In its own words, from its 10-K, filed Mar 27, 2026.
LogicMark against its Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +17% against the peers' median +10%. Operating margin: -47.6% against the peers' median 16.4%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LGMK LogicMark | Q2 2026 | $3.3M | +17% | -47.6% |
| ISRG Intuitive Surgical | Q3 2026 | $3.0B | +22% | 19.4% |
| ZBH Zimmer Biomet Holdings | Q3 2026 | $2.1B | +3% | 14.9% |
| EW Edwards Lifesciences | Q3 2026 | $1.7B | +10% | 17.4% |
| STE Steris | Q2 FY27 | $1.6B | +9% | 18.5% |
| ALGN Align Technology | Q3 2026 | $1.0B | +2% | 16.7% |
| ENOV Enovis | Q3 2026 | $559M | +2% | 0.6% |
| MSA MSA Safety | Q3 2026 | $536M | +14% | 16.4% |
| CDRE Cadre Holdings | Q3 2026 | $203M | +30% | 14.0% |
Source: LogicMark 10-Q on SEC EDGAR · CIK 1566826 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
More on LGMK
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results